Wells Fargo Maintains Equal-Weight on Amgen, Lowers Price Target to $430
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $435 to $430.
Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $435 to $430.